PUBLIC FUNDS × PRIVATE CAPITAL × AGING SCIENCE VENTURES

LONGEVITY INVESTMENT TRACKER

Where Capital Meets the Science of Aging

The longevity economy is converging — public ETFs tracking aging populations and genomics, venture capital pouring billions into cellular reprogramming and senolytics, and a new class of pure-play longevity stocks. This dashboard maps the full investment landscape in one view.

LIVE MARKET DATA
$0
Total ETF Market Cap
0
Funds Tracked (11 ETF + 8 VC)
$0
2024 Longevity Capital
$0
Projected Market 2035
▴
ETF PERFORMANCE — INDIVIDUAL CHARTS
YTD price trends for each tracked longevity ETF — Jan 2 to Mar 31, 2026
Current Total
—
ETF AUM
—
Stock Market Cap
—
YTD Change
—
△
PUBLIC MARKETS — ETF PORTFOLIO
11 exchange-traded funds spanning aging demographics, genomics, biotech, and medical devices
♦
PRIVATE MARKETS — LONGEVITY VENTURE CAPITAL
8 private funds and labs dedicated to extending human healthspan and lifespan
◆
INDIVIDUAL STOCKS — LONGEVITY PURE PLAYS
Publicly-traded companies with direct longevity research exposure
Ticker Company Focus Area View
■
LONGEVITY SECTOR LANDSCAPE
Major research categories and the leading companies in each vertical